"Administer" or "administration." The direct application or
consumption of an opioid, controlled substance or other drug by
an individual, whether by injection, inhalation, ingestion or
any other means.
"Commonwealth agency." An office, department, authority,
board, multistate agency or commission of the executive branch.
"Controlled substance." As defined in section 2 of the act
of April 14, 1972 (P.L.233, No.64), known as The Controlled
Substance, Drug, Device and Cosmetic Act.
"Counterfeit." A controlled substance, other drug, device or
cosmetic or the container or labeling of which, without
authorization, bears the trademark, trade name or other
identifying mark, imprint, number or device or any likeness of a
manufacturer, distributor or dispenser other than the person who
in fact manufactures, distributes or dispenses the controlled
substance or other drug, device or cosmetic and which is falsely
purported or represented to be the product of, or to have been
distributed by, another manufacturer, distributor or dispenser.
"Department." The Department of Health of the Commonwealth.
"Designer drug." A substance other than a controlled
substance that is intended for human consumption and that either
has a chemical structure substantially similar to that of a
controlled substance in Schedule I, II or III of The Controlled
Substance, Drug, Device and Cosmetic Act or that produces an
effect substantially similar to that of a controlled substance
in Schedule I, II or III.
"Drug." As defined in section 2 of The Controlled Substance,
Drug, Device and Cosmetic Act.
"Entity." A government agency or nongovernmental agency.
" Government agency ." Any Commonwealth agency or any county,
20190HB2070PN2911 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30